6-Sinapoyllutonarin

CAS No. 1016970-96-9

6-Sinapoyllutonarin( ——— )

Catalog No. M38559 CAS No. 1016970-96-9

Isoorientin-7-O-[6-sinapoyl]-glucoside is a phenolic compound that can be isolated from the leaves of barley.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    6-Sinapoyllutonarin
  • Note
    Research use only, not for human use.
  • Brief Description
    Isoorientin-7-O-[6-sinapoyl]-glucoside is a phenolic compound that can be isolated from the leaves of barley.
  • Description
    Isoorientin-7-O-[6-sinapoyl]-glucoside is a phenolic compound that can be isolated from the leaves of barley.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1016970-96-9
  • Formula Weight
    816.71
  • Molecular Formula
    C38H40O20
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ferreres F, et al. Further knowledge on barley (Hordeum vulgare L.) leaves O-glycosyl-C-glycosyl flavones by liquid chromatography-UV diode-array detection-electrospray ionisation mass spectrometry. J Chromatogr A. 2008 Feb 22;1182(1):56-64. ?
molnova catalog
related products
  • [Tyr8] Substance P

    [Tyr8]-Substance P is an active peptide. [Tyr8]-Substance P can be used for the research of various biochemical.

  • Disomotide TFA 18147...

    Disomotide?is an oligopeptide for the treatment of melanoma.

  • Mogroside III-A2

    Mogroside III-A2 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.